Business ❯Pharmaceuticals

Research and Development

Clinical Trials Natural Products Specialty Medicines Investment Global Operations KarXT

Boehringer Ingelheim Reports Strong 2024 Growth and Prepares for New Product Launches in 2025

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

Oyster Blood Shows Potential in Combating Antibiotic-Resistant Superbugs

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal